Vaccine Therapy With PROSTVAC/TRICOM and Flutamide Versus Flutamide Alone to Treat Prostate Cancer

NCT00450463 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

64

Enrollment

NIH

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Sargramostim (GM-CSF, Leukine)
DRUG: Flutamide (Eulexin)
BIOLOGICAL: PROSTVAC-F/ TRICOM
BIOLOGICAL: PROSTVAC-V/TRICOM

Sponsor

National Cancer Institute (NCI)